A NEW COPPER (II)-IMIDAZOLE DERIVATIVE EFFECTIVELY INHIBITS REPLICATION OF DENV-2 IN VERO CELL

Authors

  • Teguh Hari Sucipto Dengue Study Group, Institute of Tropical Disease, Airlangga University, Kampus C Jl. Mulyorejo, Surabaya, East Java, Indonesia, 60115
  • Siti Churrotin
  • Harsasi Setyawati
  • Fahimah Martak
  • Kris Cahyo Mulyatno
  • Ilham Harlan Amarullah
  • Tomohiro Kotaki
  • Masanori Kameoka
  • Masanori Kameoka
  • Subagyo Yotopranoto
  • Soegeng Soegijanto

DOI:

https://doi.org/10.21010/Ajid.v12i1S.17

Keywords:

DENV-2, Antiviral activity, Vero cell, [Cu(2, 4, 5-triphenylimidazole)2]n

Abstract

Background: Dengue is a kind of infectious disease that was distributed in the tropical and sub-tropical areas. To date, there is no clinically approved dengue vaccine or antiviral for humans, even though there have been great efforts towards this end. Therefore, finding the effective compound against dengue virus (DENV) replication is very important. Among the complex compounds, copper(II)-imidazole derivatives are of interest because of their biological and medicinal benefits. Materials and Methods: In the present study, antiviral activity of [Cu(2,4,5-triphenylimidazole)2]n, was evaluated against different stages of dengue virus type 2 (DENV-2) replication in Vero cell using focus forming unit reduction assay and quantitative ELISA. Results: [Cu(2,4,5-triphenylimidazole)2]n inhibited DENV-2 replication in Vero cells with IC50 = 2.3 μg/ml and SI= 19.42 when cells were treated 2 days after virus infection, whereas its CC50 for cytotoxicity to Vero cells was 44.174 μg/ml. Conclusion: The compound has high anti-DENV2 activity, less toxicity, and a high possibility to be considered a drug candidate.

Author Biography

Teguh Hari Sucipto, Dengue Study Group, Institute of Tropical Disease, Airlangga University, Kampus C Jl. Mulyorejo, Surabaya, East Java, Indonesia, 60115

Dengue Study Group, Institute of Tropical Disease, Airlangga University, Kampus C Jl. Mulyorejo, Surabaya, East Java, Indonesia, 60115

Downloads

Published

2018-03-07

How to Cite

Sucipto, T. H., Churrotin, S., Setyawati, H., Martak, F., Mulyatno, K. C., Amarullah, I. H., Kotaki, T., Kameoka, M., Kameoka, M., Yotopranoto, S., & Soegijanto, S. (2018). A NEW COPPER (II)-IMIDAZOLE DERIVATIVE EFFECTIVELY INHIBITS REPLICATION OF DENV-2 IN VERO CELL. African Journal of Infectious Diseases (AJID), 12(1S), 116–119. https://doi.org/10.21010/Ajid.v12i1S.17

Issue

Vol. 12 No. 1S (2018): Special Issue

Section

Articles

License

Copyright: Creative Commons Attribution CC BY This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.